Background. Delirium following cardiac surgery is a relevant complication in the majority of elderly patients but its prediction is challenging. Cardiopulmonary bypass, essential for many interventions in cardiac surgery, is responsible for a severe inflammatory response leading to neuroinflammation and subsequent delirium. Neurofilament light protein (NfL) and tau protein (tau) are specific biomarkers to detect neuroaxonal injury as well as glial fibrillary acidic protein (GFAP), a marker of astrocytic activation. Methods. We thought to examine the perioperative course of these markers in a case series of each three cardiac surgery patients under off-pump cardiac arterial bypass without evolving delirium (OPCAB-NDEL), patients with a procedure under cardio-pulmonary bypass (CPB) without delirium (CPB-NDEL) and delirium after a CPB procedure (CPB-DEL). Delirium was diagnosed by the Confusion Assessment Method for the ICU and chart reviews. Results. We observed increased preoperative levels of tau in patients with later delirium, whereas values of NfL and GFAP did not differ. In the postoperative course, all biomarkers increased multi-fold. NfL levels sharply increased in patients with CPB reaching the highest levels in the CPB-DEL group. Conclusion. Tau and NfL might be of benefit to identify patients in cardiac surgery at risk for delirium and to detect patients with the postoperative emergence of delirium.
INTRODUCTION
Neurocognitive dysfunction after cardiac surgery is relevant in the majority of elderly patients because it impairs quality of life and often leads to the need for institutionalized care 1 . It remains challenging to predict which patients will suffer adverse cognitive events when undergoing cardiac surgery. The known risk factors for delirium and postoperative cognitive decline include patient frailty, preexisting cognitive impairment, mental health problems including depression and age 2 . A local stimulus due to surgery or trauma is believed to induce systemic inflammation followed by neuroinflammatory responses 3 and an activation of microglia which leads to neuronal damage 4 .
This cascade is meant to be crucial in the pathogenesis of delirium. In cardiac surgery the inflammatory stimulus causing endothelial activation is induced by the artificial surface of the cardiopulmonary bypass (CPB) circuit 5 in contrast to arterial bypass surgery without CPB in offpump cardiac arterial bypass (OPCAB) surgery. A contact activation of the immune system is held responsible for the severe inflammatory response syndrome (SIRS) often observed after cardiac surgery under CPB and might result in the high incidence rates of delirium in these patients 6 .
An increase in biomarkers of neurodegeneration has been observed in experimental and clinical studies 6, 7 in cardiac surgery and is associated with long-term cognitive impairment 7, 8 . Neuroinflammation is discussed to be a critical factor in the emergence of delirium and neuroaxonal injury to the brain 3, 9 . Few studies have focused on the development of markers of neuroinflammation and neurodegeneration in the early phase following cardiac bypass surgery 7, 10 .
Neurofilament proteins (Nf) are specific biomarkers to detect neuroaxonal injury 11, 12 . Neurofilament light (NfL) and heavy (NfH) chain levels were found to be increased in various diseases like multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Morbus Parkinson or sepsis-associated encephalopathy (SAE) (ref. [13] [14] [15] ). The value of tau and NfL levels to detect and monitor delirium in cardiac surgery patients is unknown. In a huge, recently published review article, Nf-L in cerebrospinal fluid was found to be useful to differentiate between neurological entities 16 .
We conducted a case series study of cardiac surgery patients to assess the value of tau protein (tau) and NfL (two markers of neuroaxonal injury), as well as glial fibrillary acidic protein (GFAP, a marker of astrocytic activation), in delirium.
Theory
We hypothesized that these biomarkers of neuroaxonal injury behaved differently between delirious and nondelirious patients and between patients with and without CPB procedure.
METHODS

Study design
All patient data of the present study were evaluated from a previous prospective, longitudinal observational biomarker study performed at the department of Anaesthesiology, University Hospital of Munich (LMU). Ethic approval was obtained from the local ethics committee (identifier 716-16) and the study was registered as a clinical trial (DRKS00011833). Written informed consent was obtained from all participants prior to study inclusion. Three groups of cardiac surgery patients were matched for age, gender, type of surgery, co-morbidities and baseline neurocognitive function. Inclusion criteria were age above 60 years and elective, single procedure cardiac surgery. Exclusion criteria comprised chronic renal disease (GFR < 60 mL/min), liver cirrhosis, preexistent mental health problems (dementia, schizophrenia, depression), pulmonary arterial hypertension, preexisting severe cognitive decline (Mini Mental Status Examination, MMSE < 24) and preoperative hemoglobin level <10 g/dL.
Group 1 (n=3) comprised patients undergoing an OPCAB procedure without developing delirium (OPCAB-NDEL). Group 2 (n=3) included patients with CPB procedure without delirium (CPB-NDEL) and group 3 (n=3) patients with a CPB procedure suffering post-operative delirium (CPB-DEL).
All patients received a standardized premedication with oral midazolam, anaesthesia was induced and con-tinued by continuous infusion of sufentanil (1 µg/kg body weight/min) and propofol (4-6 mg/kg body weight/h). Serum samples were taken at the day before surgery (T0), after surgery at entrance to the intensive care unit (ICU) (T1), at postoperative day 1 (T2) and at day 3 after surgery (T3) as well as at the day of discharge from hospital (4-30 days, T4).
Biomarkers of neuroaxonal injury
NfL protein levels were determined by a single molecule array (Simoa) method (Quanterix Corporation, Lexington, MA, USA) with monoclonal antibodies and calibrator (UmanDiagnostics, Umea, Sweden) at the Department of Radiochemistry, Gothenburg University, Mölndal, Sweden using a single batch of reagents, with intra-assay coefficients of variation <10% (ref. 17 ). The levels of tau and GFAP were analyzed by a commercial enzyme-linked immunosorbent assays (Fujirebio Europe, Ghent, Belgium) and with an in-house assay as described before 18 .
Delirium assessment
All patients were clinically assessed for signs of delirium using the validated Confusion Assessment Method for the ICU (CAM-ICU) by nurses and physicians experienced in delirium screening and management 19, 20 . CAM-ICU was performed at least three times per day by nurses and additionally twice per day by the study team and completed with a chart review.
Statistical analysis
The Shapiro Wilk test was used to test for normally distributed values. For not normally distributed data, we present median values (25th-75th percentile) and used the Kruskal-Wallis-Test for intragroup differences and the Friedman's test for the postoperative course of biomarker values. Categorial data were evaluated by a Chi-Squared Test and Fisher's exact test. Differences were considered to be significant with an α=5% (P=0.05). Associations were indicated by the Spearman-Rho correlation coefficient. All statistical analyses were performed in SPSS (IBM SPSS Statistics, Version 24, Armonk, NY, USA).
RESULTS
Patient characteristics
Nine patients were retrospectively evaluated in the course of cardiac surgery (see Table 1 ). The mean dosage of norepinephrine during anaesthesia was 0.09±0.05 µg/kg/min. The mean blood loss was 934±1012 mL (231±72 mL heparinized and washed autologous blood re-transfused). No patient received homologous blood transfusion. Two patients, case #6 and #8, received platelet concentrates during the course of surgery. Patients were extubated after a mean ventilation time of 13.7±3.8 h after ICU admission and received dexmedetomidine and propofol if additional sedation was required before the endotracheal tube could be removed.
Preoperative levels of tau, NfL and GFAP
Preoperative mean levels of tau protein were significantly increased in the CPB-DEL group (1.567±0.252 ng/ mL) compared to the OPCAB-NDEL group (0.900±0.265 ng/mL; P=0.05) and the CPB-NDEL group (0.933±0.379 ng/mL; P=0.05; Fig. 1 ).
Preoperative NfL levels were not significantly different between the CPB-DEL group (71.0±38.17 pg/mL) compared to CPB-NDEL patients (37.1±11.3 pg/mL) and the OPCAB-NDEL group (35.7±15.2 pg/mL; P=0.827; Fig. 1 ).
Furthermore, no differences between the three groups were observed for the preoperatively measured GFAP values ( Fig. 1 ).
Longitudinal development of tau, NfL and GFAP levels after surgery
Tau levels significantly increased several-fold in all three groups (P=0.013) after surgery reaching the individual peak concentration of 16 ng/mL at T1 (P=0.021) and nearly a return to basal values in all patient groups ( Fig. 2a ). At the first postoperative day, mean tau concen-trations were 2.9 in the OPCAB-NDEL, 2.4 in the CPB-NDEL and 8.0 ng/mL in the CPB-DEL group, reflecting a 2.6, 2.4 and 5.0-fold increase from baseline, respectively. NfL levels only slightly increased to an individual peak concentration of 94.3 pg/mL in the OPCAB-NDEL group (41% increase from baseline, peak at T3, Figure  2b ). Within the CPB-NDEL group a stronger increase of NfL levels to a mean peak concentration of 88 pg/mL (about 2-fold increase from baseline, peak at T2) was observed. The strongest increase of NfL levels was detected in the CPB-DEL group with peak concentrations above 100 pg/mL (and several-fold mean increase from baseline (P=0.011), peak at T4 (P=0.002), Fig. 2b ).
No differences between the groups were observed for the development of GFAP levels over time (P=0.091). Every patient experienced at least a distinct, almost twofold increase, with its perioperative maximum in different points of time (Fig. 2 c) . This was not specifically related to delirium or the type of surgery. However, levels of GFAP were associated with values of NfL on postoperative day one (r=0.800; P=0.01) and at discharge (r=0.821; P=0.023). 
DISCUSSION
We present a case series of nine patients undergoing cardiac surgery. All patients had comparable preoperative conditions for cognitive as well as intraoperative features and neither preexisting neurocognitive impairment nor other neurologic disease before surgery. Therefore, our data might give some important insights into the longitudinal development of biomarkers of neurodegeneration after cardiac surgery.
The idea to use biomarkers for neurodegeneration is to address two main diagnostic shortcomings in patients with delirium. First, the preoperative identification of patients at high risk for the emergence of postoperative delirium. Present tools for delirium prediction have proven to be insufficient 21 . Second, the early detection of delirium during the postoperative phase. Both shortcomings are highly relevant for intensivists as critically ill patients can-not easily be assessed clinically for signs of delirium due to sedation or mechanical ventilation. The identification of patients at high risk for delirium might enable the clinical personnel to perform a closer delirium screening and monitoring and, if necessary, an early start of delirium treatment. This is important as the duration of delirium is associated with impaired outcome 21 . Given the different pathophysiological hypotheses on delirium, the biomarker guided detection of the emerging delirium and the monitoring of a present delirium might allow to discriminate between patients with a transient delirium without brain injury and patients with the emergence of structural brain damage 22 . Especially these patients could profit from longitudinal biomarker measurements to perform brain imaging in a timely manner, to adapt treatment strategies and to prevent long-term neurocognitive impairment.
There are some important conclusions that can be drawn from our data. The biomarkers tau, GFAP and NfL showed a completely different behavior in the cardiac surgery patients of the present study. Among all three biomarkers, GFAP levels seemed to be least suitable for delirium prediction, detection and monitoring as no relevant differences were observed between the three patient cohorts. These observations correspond with previous data derived from a non-cardiosurgical cohort with no association between CSF GFAP levels and delirium 23 . The release of GFAP, as a structural protein of astrocytes, is usually associated with acute brain damage such as traumatic brain injury 24 . However, we did not notice complications like stroke or seizures leading to manifest brain injury in our patients. Results from brain imaging were not available, which is a limitation of the present study. We cannot exclude that structural brain injury was present in some of our patients. Brain imaging should be therefore part of a future study protocol.
The higher preoperative tau protein levels in patients with CPB and delirium (CPB-DEL group) compared to the two other groups suggest that tau measurements might be of value to predict postoperative delirium in cardiac surgery patients. In line with our observations, Simons et al. reported higher tau levels in patients with emerging hypoactive delirium 25 . We speculate that patients with higher tau levels in our study had subclinical neurological impairment that was not detected by the MMSE. This test might not have been sensitive enough to detect neurocognitive dysfunction at early stages, which advocates preoperative Tau measurements in cardiac surgery patients.
The development of the NfL was completely different to tau and GFAP (ref. 26 ). The increase of NfL over time might indicate that this biomarker is relevant for the detection and monitoring of the emerging delirium. Without significant differences in the basal neurofilament levels between the three groups, the increase of NfL levels over time was much greater in patients with delirium and CPB compared to patients without delirium or OPCAB. The lower increase of NfL levels in the OPCAB-NDEL group suggests that a minor systemic inflammatory stimulus might have been induced due to the absence of CPB procedure. These observations support the previously discussed link between systemic inflammation and a neuroinflammatory response within the central nervous system 9 .
NfL as a specific marker of neuronal damage tended to increase at the end of our observation period. In contrast to NSE and S100B, which are known to show a decrease quickly after brain damage, NfL might better indicate neuroaxonal injury leading to cognitive decline beyond delirium. Due to the small number of participants within the present study, some longitudinal biomarker developments are not easily comprehensible. A conspicuous case was patient #7 (CPB-DEL group), who experienced a short, but intense course of delirium. In this case, levels of NfL prior to surgery were below the level of quantification (<1.28 pg/mL). As a mathematician with an academic career, this patient was the only participant holding a university degree. Besides, he had the strongest increase in NfL levels (about factor 30). It is striking that the highest concentration of NfL in this patient was reduced until discharge by factor three. NfL levels of the other two CPB-DEL patients increased further until discharge. The notion of a high educational standard being protective in developing delirium is controversially discussed 27, 28 . This association might either be based on a sufficient clearing mechanism for neurotoxic substances and debris detrimental for brain functioning 29 or a stronger constitution of the brain less sensitive to neurodegeneration 4 .
Another interesting case was subject #6, who did not experience delirium, but had an extraordinary increase in NfL until the day of discharge. This was the only patient with a prolonged ICU stay and repeated surgery (drainage of pericardial effusion). As we did not prospectively examine this patient for delirium during the four weeks of his hospital stay, a subsyndromal delirium might have been present. Certainly, in our chart review, there was no hint on delirium.
The longitudinal development of NfL levels showed a peak concentration at the day of discharge in all patients with the exception of patient #3 (OPCAB) and patient #7. The hypothetical value of NfL measurements for the perception of long-term neurocognitive impairment is unclear and should be evaluated by further studies. It is imperative to collect samples in a much longer period of time than we did in our study to find the turning point of NfL in the perioperative course, reflecting the reversal of neurodegenerative activity following cardiac surgery which leads to cognitive decline. Other markers of neuronal damage like NSE and S100B might be useful, but previous studies were not able to give strong evidence for their value to detect and predict delirium 30, 31 .
Those individuals having high preoperative NfL levels (>40 pg/mL) experienced delirium or other complications (cases #6, #8 and #9) when being exposed to CPB. One conclusion might be that the incidence of increased NfL reflects a higher vulnerability of the brain to exogenous triggers such as infection or CBP and might increase the risk to develop delirium. This could enable physicians in the future to adapt treatment strategies, e.g. alternative surgical (OPCAB) or anaesthesiological (regional anaesthesia) approaches to reduce the risk of delirium and to improve long-term neurocognitive patient outcome.
CONCLUSION
With the present case series, we demonstrated the potential value of tau and NfL levels to predict and detect delirium after cardiac surgery. Cardiopulmonary bypass procedure might have significant impact on the emergence of postoperative delirium represented by increasing biomarkers of neuroaxonal injury. Further prospective, well-powered studies should focus on these biomarkers in a broader time frame to thoroughly document their association with and their value for delirium.
